Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Itraconazole is potentially effective for treating invasive aspergillosis, but more research is needed.

Fibrinogen/LDL apheresis may improve speech perception in sudden hearing loss, especially for those with high fibrinogen and LDL levels.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Biotin treatment can significantly improve hair loss and motor functions in certain metabolic disorders.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Folliculitis is an inflammation of hair follicles that requires proper diagnosis and treatment based on the specific cause.

Lithium therapy may cause skin problems like hidradenitis suppurativa and other side effects, which can improve after stopping the medication.

Photothermal hydrogels are promising for infection control and tissue repair, and combining them with other treatments could improve results and lower costs.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

COVID-19 may cause hair loss due to infection stress or treatments.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Fibroblasts, cells usually linked to tissue repair, also help regenerate various organs and their ability decreases with age. Turning adult fibroblasts back to a younger state could be a new treatment approach.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Patients with GATA2 deficiency show early skin symptoms that help diagnose the condition.

Finasteride worsens seizures in epilepsy rats and speeds up epileptogenesis in mice.

Hibiscus rosa-sinensis may help treat various health issues and promote hair growth, but more research is needed for safety.

Men with hair loss have more DNA changes in back-of-head hair follicles, possibly protecting them from thinning.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

HPV16 oncogenes disrupt the normal activity of hair follicle stem cells.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.